anonymous
Guest
anonymous
Guest
You tell em’, Karen.Yes.
This site is for the Esperion Scientific Hires, Highly Tenured Customer Facing Team and Lipid Trained Experts.
So stay off.
ESPR down again today.
You tell em’, Karen.Yes.
This site is for the Esperion Scientific Hires, Highly Tenured Customer Facing Team and Lipid Trained Experts.
So stay off.
ESPR down again today.
My understanding is there’s a big hospitality tent, haven’t heard about tickets.
Brad and the company are really on a roll, and this exposure is part of the magic that is turning the ship around. Our future looks solid as we race ahead in our fight against CAD.
Oh boy.
More word salad from a Scientific Hire.
It’s looking more and more likely that DS is going to have to cough up to 300 million based on the CLEAR outcomes data. The primary prevention data is awesome, it’s going to be very difficult to weasel out of the agreement. Commercialization remains somewhat elusive however the most recent trends are encouraging, and the public exposure from NASCAR seems like a smart move. There is much to like about the present outlook.
Stock trends not encouraging also. Down over 7% today at $1.42. We're still considered a struggling penny stock. What a joke!!! What is management doing????
Hope your right with regard to DS, things will get ugly very quickly if not. Sales trends are not really that encouraging, clear bump post ACC, but then it seems to plateau again, growth needs to be in triple digits to be compelling.
Did not get hiredLoss of > $111 million for the first six months of 2023. Let that sink in.
But, loss of >$123 million for the first six months of 2022.
Money burn continues.
Is this progress ?
Leave it to the Ann Arbor lackey to keep up BS posts and deflect what a shithole Esperion is. What is pathetic is you monitoring this site 24/7. Your adversary hasn't posted in months but you take the bait everytime schmuck.
Dumbass KarenGod help us. This has been quite an adventure since 2020 with all the corporate idiots doing everything to derail a decent drug. Please somebody take the reins!!!
Loss of > $111 million for the first six months of 2023. Let that sink in.
But, loss of >$123 million for the first six months of 2022.
Money burn continues.
Is this progress ?
Loss of > $111 million for the first six months of 2023. Let that sink in.
But, loss of >$123 million for the first six months of 2022.
Money burn continues.
Is this progress ?